Date: 2017-03-16
Type of information: Nomination
Compound:
Company: Biogen (USA - MA)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On March 16, 2017, Biogen announced the appointment of Anirvan Ghosh, as senior vice president, Research and Early Development (RED). Dr. Ghosh will lead Biogen’s RED organization in the discovery and development of drug candidates from idea through proof of concept. He will report to Michael Ehlers, M.D., Ph.D., executive vice president, Head of Research and Development. Dr. Ghosh will begin his service at Biogen in April. He joins Biogen from E-Scape Bio, where he served as chief scientific officer. Prior to heading discovery efforts for Alzheimer’s disease and neurodegenerative disorders at E-Scape Bio, he served as vice president, Global Head of Neuroscience Discovery and Biomarkers at Roche. In this capacity, Dr. Ghosh led research and drug discovery for programs addressing neurodegenerative diseases as well as neurodevelopmental and psychiatric disorders. Prior to joining industry, Dr. Ghosh served as a professor on the neuroscience faculties of the Johns Hopkins University and the University of California, San Diego. His academic research has focused on understanding how connections in the brain are established during development and how these connections may be affected in neurodevelopmental disorders. Dr. Ghosh received a BS in Physics from the California Institute of Technology, a Ph.D. in Neuroscience from Stanford University, and postdoctoral training at Harvard Medical School. He is the author of more than 90 scientific publications.
Financial terms:
Latest news:
